Table 3 Concordance between GIS and shallowHRDv2 test on 31 tumor samples from Poitiers Hospital routine laboratory.

From: Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trial

 

ShallowHRDv2

Positive

Negative

NC

GIS

Positive

8

2

0

Negative

1

18

0

NC

0

0

2

  1. NC non-contributive.
Back to article page